The latest from DTC Perspectives
Looking For Bad Guys
Friday, 12 March 2010, 08:21 AM
The search for drug company evil continues as Glaxo’s Avandia is the latest drug in the crosshairs of regulators, the media and lawyers. This diabetes drug is highly effective at regulating blood sugar and is used by millions of type 2 diabetics. It may have a higher risk of causing heart attacks than some alternate therapies and placebo according to some studies read more
Inside the March 2010 issue of DTC Perspectives magazine
Monday, 08 March 2010, 04:08 PM
Former Vermont Gov. Howard Dean has been vocal during the healthcare reform debate about the need for “real” reform. He shares some of his thinking on this topic with DTC Perspectives in advance of his presentation at the DTC National in April. Also featured, KantarHealth’s Ken Sobel sheds some light on public policy myths – does DTC really drive up the costs of consumer-advertised products? read more
The Bleeding Has Stopped!
Friday, 05 March 2010, 08:14 AM
Despite some critics saying DTC was heading to a permanent downturn, after a serious first half 2009 decline, the second half was so positive the year ended up. Spending ended up 2% according to data from Kantar Media. Usually I do not get excited about 2% increases. In this instance I am thrilled because I did not see growth until 2011, after I predicted a flat 2010 when I thought the bleeding would stop. read more
Health Summit Promising Start
Friday, 26 February 2010, 08:00 AM
One of the benefits of a home office is I can watch television so I watched the six hour summit. I thought it was promising in that there is a wide area of agreement on goals albeit a cavernous gap in how to do it. read more
A World Without DTC?
Friday, 19 February 2010, 08:08 AM
Critics constantly call for a ban on DTC. The most common claim is that DTC raises treatment cost because advertised branded drugs are often not better than generics, lifestyle changes, or other non-prescription remedies. They also say DTC creates imagined disease categories which cause people to demand expensive treatments for questionable conditions. They argue the DTC drugs overstate benefits without properly giving the risks. Critics bemoan the fact that the doctor-patient relationship is harmed by patient initiated discussions and demand read more
Major Pharmaceutical Brands Vie For Top Honors at DTC National Advertising Awards
Thursday, 18 February 2010, 08:58 AM
Several leading pharmaceutical companies and brands will be honored at the tenth annual DTC National Conference's much-anticipated Advertising Awards dinner April 8, an event that will showcase the best marketing and advertising across 8 categories. Among the brands with multiple "finalist" designations are Advair & Treximet, GlaxoSmithKline; Seroquel XR, AstraZeneca; Pristiq, Pfizer and Vyvanse, Shire. The 2010 DTC National Ad Awards Dinner is sponsored by HealthGrades. read more
Prevention and Cost Control
Friday, 12 February 2010, 08:28 AM
The First Lady this week has announced a new push to fight childhood obesity. Michelle Obama’s cause is the kind of push needed to lower the health care cost curve long-term. We, as a nation, are getting fatter year by year and clearly our obesity related diabetes and heart disease will on its current path eventually bankrupt our health care system. Thirty years ago the teen age obesity rate was 5%, and now it is almost 18%. That is a huge change in one generation and portends a huge increase in future diabetes and heart disease cases. There read more
Top 25 DTC Marketers of the Year Announced
Thursday, 11 February 2010, 11:20 AM
The Top 25 Marketers of the Year Awards are sponsored by PARADE magazine, in conjunction with the DTC National Conference, April 7-9, 2010 at the J.W. Marriott Hotel in Washington D.C. read more
A More Vigilant FDA
Friday, 05 February 2010, 08:25 AM
The latest data from FDA shows warning letters on drug promotion almost doubled in 2009 to 41 from 21 in 2008. That is not surprising given the changes in Washington. Clearly the Democrats are demanding more enforcement actions against drug companies, which they saw as lax under Bush. read more
Growth in New Categories
Friday, 29 January 2010, 08:18 AM
While the traditional definition of DTC advertising is for pills, inhalers, devices and injections to treat medical condition or illness; the growth drivers may come from other DTC categories. One of the major growth areas will be in aesthetic products. A new report from Global Markets Direct predicts solid annual growth from cosmetic procedures forecast at 6.5% per year through 2016. read more
DTC and You
Mark Your Calendar for the DTC National Conference
The DTC National Conference
will be held in JW Marriott Hotel on April 7-9, 2010.
Don't miss the forum for DTC Thought Leaders.
FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
DTC Perspectives Magazine is published quarterly.
Subscribe to DTC Insights
The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.
Subscribe to Bob Ehrlich’s newsletter
A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry
| ABOUT SSL CERTIFICATES |
